SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-24-247920
Filing Date
2024-10-31
Accepted
2024-10-31 06:39:47
Documents
17

Document Format Files

Seq Description Document Type Size
1 S-1/A d878566ds1a.htm S-1/A 423088
2 EX-4.2 d878566dex42.htm EX-4.2 80183
3 EX-4.3 d878566dex43.htm EX-4.3 77665
4 EX-4.4 d878566dex44.htm EX-4.4 84127
5 EX-5.1 d878566dex51.htm EX-5.1 20280
6 EX-5.2 d878566dex52.htm EX-5.2 9148
7 EX-8.1 d878566dex81.htm EX-8.1 8655
8 EX-10.23 d878566dex1023.htm EX-10.23 42255
9 EX-10.24 d878566dex1024.htm EX-10.24 185195
10 EX-23.1 d878566dex231.htm EX-23.1 3792
11 EX-FILING FEES d878566dexfilingfees.htm EX-FILING FEES 32646
12 GRAPHIC g878566dsp001.jpg GRAPHIC 5971
13 GRAPHIC g878566dsp002.jpg GRAPHIC 3404
14 GRAPHIC g878566g00h01.jpg GRAPHIC 39737
15 GRAPHIC g878566g00p01.jpg GRAPHIC 43107
16 GRAPHIC g878566g0801172147431.jpg GRAPHIC 2344
17 GRAPHIC g878566g1028233940492.jpg GRAPHIC 3728
  Complete submission text file 0001193125-24-247920.txt   1104394
Mailing Address 66 WELLINGTON STREET WEST, SUITE 5300 TD BANK TOWER BOX 48 TORONTO A6 M5K 1E6
Business Address 66 WELLINGTON STREET WEST, SUITE 5300 TD BANK TOWER BOX 48 TORONTO A6 M5K 1E6 310-849-8060
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-281201 | Film No.: 241412339
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)